CAPTRUST Financial Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.6M | Buy |
392,564
+7,846
| +2% | +$700K | 0.06% | 247 |
|
|
2026
Q1 | $27.6M | Buy |
384,718
+14,912
| +4% | +$1.15M | 0.05% | 299 |
|
|
2025
Q4 | $29.3M | Buy |
369,806
+112,196
| +44% | +$8.84M | 0.06% | 256 |
|
|
2025
Q3 | $19.4M | Buy |
257,610
+7,804
| +3% | +$535K | 0.04% | 324 |
|
|
2025
Q2 | $17.2M | Sell |
249,806
-30,750
| -11% | -$2.02M | 0.04% | 342 |
|
|
2025
Q1 | $19M | Buy |
280,556
+6,545
| +2% | +$392K | 0.05% | 296 |
|
|
2024
Q4 | $12.3M | Sell |
274,011
-128,335
| -32% | -$7.2M | 0.04% | 329 |
|
|
2024
Q3 | $25.3M | Sell |
402,346
-122,218
| -23% | -$7.13M | 0.08% | 197 |
|
|
2024
Q2 | $31M | Sell |
524,564
-1,368,315
| -72% | -$85.6M | 0.1% | 163 |
|
|
2024
Q1 | $137M | Buy |
1,892,879
+88,113
| +5% | +$6.73M | 0.5% | 41 |
|
|
2023
Q4 | $143M | Buy |
1,804,766
+13,429
| +0.7% | +$956K | 0.49% | 40 |
|
|
2023
Q3 | $125M | Buy |
1,791,337
+63,663
| +4% | +$4.51M | 0.48% | 44 |
|
|
2023
Q2 | $119M | Buy |
1,727,674
+344,030
| +25% | +$24.5M | 0.47% | 42 |
|
|
2023
Q1 | $103M | Buy |
1,383,644
+94,078
| +7% | +$7.89M | 0.45% | 46 |
|
|
2022
Q4 | $120M | Buy |
1,289,566
+58,075
| +5% | +$5.6M | 0.6% | 33 |
|
|
2022
Q3 | $117M | Buy |
1,231,491
+97,971
| +9% | +$9.7M | 0.68% | 26 |
|
|
2022
Q2 | $105M | Buy |
1,133,520
+138,048
| +14% | +$13.5M | 0.68% | 27 |
|
|
2022
Q1 | $101M | Buy |
995,472
+95,160
| +11% | +$10M | 0.65% | 24 |
|
|
2021
Q4 | $92.9M | Buy |
900,312
+286,437
| +47% | +$26.5M | 0.64% | 30 |
|
|
2021
Q3 | $52.1M | Buy |
613,875
+59,089
| +11% | +$4.95M | 0.43% | 54 |
|
|
2021
Q2 | $46.3M | Buy |
554,786
+29,792
| +6% | +$2.44M | 0.43% | 54 |
|
|
2021
Q1 | $39.5M | Buy |
524,994
+39,644
| +8% | +$2.89M | 0.43% | 50 |
|
|
2020
Q4 | $33.1M | Buy |
485,350
+36,999
| +8% | +$2.41M | 0.44% | 52 |
|
|
2020
Q3 | $25.9M | Buy |
448,351
+83,563
| +23% | +$5.2M | 0.43% | 48 |
|
|
2020
Q2 | $23.6M | Buy |
364,788
+95,283
| +35% | +$6M | 0.39% | 67 |
|
|
2020
Q1 | $15.7M | Sell |
269,505
-26,270
| -9% | -$1.75M | 0.35% | 75 |
|
|
2019
Q4 | $21.9M | Buy |
295,775
+109,014
| +58% | +$7.65M | 0.35% | 76 |
|
|
2019
Q3 | $11.8M | Buy |
186,761
+6,874
| +4% | +$407K | 0.41% | 55 |
|
|
2019
Q2 | $9.8M | Buy |
179,887
+21,313
| +13% | +$1.15M | 0.36% | 61 |
|
|
2019
Q1 | $8.55M | Buy |
158,574
+4,077
| +3% | +$252K | 0.35% | 62 |
|
|
2018
Q4 | $10.1M | Buy |
154,497
+22,271
| +17% | +$1.66M | 0.54% | 41 |
|
|
2018
Q3 | $10.4M | Buy |
132,226
+54,907
| +71% | +$3.93M | 0.47% | 38 |
|
|
2018
Q2 | $4.97M | Buy |
77,319
+2,136
| +3% | +$141K | 0.28% | 67 |
|
|
2018
Q1 | $4.59M | Sell |
75,183
-6,214
| -8% | -$446K | 0.28% | 67 |
|
|
2017
Q4 | $5.9M | Buy |
81,397
+81,366
| +262,471% | +$5.92M | 0.36% | 59 |
|
|
2017
Q3 | $2K | Buy |
+31
| New | +$2.45K | ﹤0.01% | 524 |
|
Other funds holding CVS
CAPTRUST Financial Advisors's CVS Position: Q2 2026 in Review
CAPTRUST Financial Advisors increased its CVS Health (CVS) stake by 2% in Q2 2026, buying an estimated $700K and bringing the position to 392,564 shares worth $40.6M. The position accounts for 0.06% of the portfolio, ranked #247.
CAPTRUST Financial Advisors first reported a position in CVS in Q3 2017 and has held it in 36 quarters since. The position peaked at $143M in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- CAPTRUST Financial Advisors held 392,564 shares of CVS Health worth $40.6M as of Q2 2026.
- CAPTRUST Financial Advisors bought 7,846 CVS Health shares in Q2 2026, an estimated $700K.
- CVS Health made up 0.06% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #247 holding.
- CAPTRUST Financial Advisors first reported a position in CVS Health in Q3 2017 and has held it in 36 quarters since.
- CAPTRUST Financial Advisors's CVS Health position peaked at $143M in Q4 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.